Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Condensed Consolidated Balance Sheets    
Cash and cash equivalents $ 14,316,461 $ 20,303,869
Other current assets 55,700 217,745
Total current assets 14,372,161 20,521,614
Operating lease right-of-use-asset 72,889 0
Total assets 14,445,050 20,521,614
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 1,914,302 1,580,543
Total current liabilities 1,914,302 1,580,543
Non-current operating lease liability 20,850 0
Total liabilities 1,935,152 1,580,543
Commitments and contingencies (Note 6)    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 12,855,735 and 12,598,125 shares issued and outstanding at September 30, 2022, and December 31, 2021, respectively 12,856 12,598
Additional paid-in capital 61,361,740 60,220,016
Accumulated other comprehensive income (loss) 42,985 (3,160)
Accumulated deficit (48,907,683) (41,288,383)
Total stockholders' equity 12,509,898 18,941,071
Total liabilities and stockholders' equity $ 14,445,050 $ 20,521,614